Active plant substance found to reduce pulmonary hypertension
Medical Xpress - Cardiology
JULY 8, 2024
Pulmonary hypertension is a very serious disease that leads to heart failure and death in many patients.
Medical Xpress - Cardiology
JULY 8, 2024
Pulmonary hypertension is a very serious disease that leads to heart failure and death in many patients.
Journal of Cardiothoracic Surgery
FEBRUARY 5, 2024
Although pulmonary artery banding (PAB) has been generally acknowledged as an initial palliative treatment for patients having single ventricle (SV) physiology and unrestrictive pulmonary blood flow (UPBF), it.
Physiologically Speaking
JANUARY 3, 2024
Cardiovascular physiology has long held that the heart is a mechanical pump and that the heart’s propulsive power is the main driver of blood flow throughout the body. While he didn't fully grasp the complete circulatory system, his insights into the pulmonary circulation were notable for the time.
Journal of Clinical Investigation - Cardiology
MARCH 1, 2024
Pulmonary surfactant is a lipoprotein complex lining the alveolar surface to decrease the surface tension and facilitate inspiration. TMEM63A/B were predominantly localized at the limiting membrane of the lamellar body (LB), a lysosome-related organelle that stores pulmonary surfactant and ATP in AT2 cells.
Physiologically Speaking
FEBRUARY 16, 2024
Welcome to the Physiology Friday newsletter. Physiologically Speaking is a reader-supported publication. There’s a long-running debate in exercise physiology about what limits VO2 max. Physiology is integrative, not isolated. To receive new posts and support my work, consider becoming a free or paid subscriber.
Open Heart
DECEMBER 14, 2023
The excess risk of COVID-19 hospitalisation and death rose with increasing physiological severity of CHD (presence of pulmonary vascular disease and/or cyanosis), rather than anatomical complexity. Of patients with a positive COVID-19 test, patients with CHD were more likely than controls to be hospitalised (22.4%
Heart BMJ
MARCH 22, 2024
Challenges in the diagnosis of pulmonary hypertension Pulmonary hypertension (PH) is a clinical–physiological syndrome thought to affect 1% of the global population. 1 PH is defined haemodynamically by mean pulmonary artery pressure >20 mm Hg, resulting in right ventricular (RV) overload and often RV failure.
Let's personalize your content